Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Balakrishna Pai

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Antiviral activity and pharmacokinetics of 1-(2,3-dideoxy-2-fluoro-beta-L-glyceropent-2-enofuranosyl)cytosineHuachun Chen, S Balakrishna Pai, Selwyn J Hurwitz, et al.
Advanced Healthcare Materials|December 12, 2018
Engineering Controlled Peritumoral Inflammation to Constrain Brain Tumor GrowthTarun Saxena, Johnathan G Lyon, S Balakrishna Pai, et al.
Cancers|November 27, 2021
Interception of Signaling Circuits of Esophageal Adenocarcinoma Cells by Resveratrol Reveals Molecular and Immunomodulatory SignaturesHardika Dhir, Monica Choudhury, Ketki Patil, et al.
Antiviral Chemistry & Chemotherapy|July 12, 2005
Characterization of hepatitis B virus inhibition by novel 2'-fluoro-2',3'-unsaturated beta-D- and L-nucleosidesS Balakrishna Pai, Rekha B Pai, Meng-yu Xie, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Emergence of a novel mutation in the FLLA region of hepatitis B virus during lamivudine therapyS Balakrishna Pai, A Mithat Bozdayi, Rekha B Pai, et al.
Biomaterials|June 24, 2015
Enhanced therapeutic neovascularization by CD31-expressing cells and embryonic stem cell-derived endothelial cells engineered with chitosan hydrogel containing VEGF-releasing microtubesSangho Lee, Chandra M Valmikinathan, Jaemin Byun, et al.
Nature Materials|February 18, 2014
Guiding intracortical brain tumour cells to an extracortical cytotoxic hydrogel using aligned polymeric nanofibresAnjana Jain, Martha Betancur, Gaurangkumar D Patel, et al.
Antiviral Chemistry & Chemotherapy|July 15, 2003
N4-acyl-modified D-2',3'-dideoxy-5-fluorocytidine nucleoside analogues with improved antiviral activityJunxing Shi, Judy S Mathew, Phillip M Tharnish, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Antiviral activity and pharmacokinetics of 1-(2,3-dideoxy-2-fluoro-beta-L-glyceropent-2-enofuranosyl)cytosineHuachun Chen, S Balakrishna Pai, Selwyn J Hurwitz, et al.
Advanced Healthcare Materials|December 12, 2018
Engineering Controlled Peritumoral Inflammation to Constrain Brain Tumor GrowthTarun Saxena, Johnathan G Lyon, S Balakrishna Pai, et al.
Cancers|November 27, 2021
Interception of Signaling Circuits of Esophageal Adenocarcinoma Cells by Resveratrol Reveals Molecular and Immunomodulatory SignaturesHardika Dhir, Monica Choudhury, Ketki Patil, et al.
Antiviral Chemistry & Chemotherapy|July 12, 2005
Characterization of hepatitis B virus inhibition by novel 2'-fluoro-2',3'-unsaturated beta-D- and L-nucleosidesS Balakrishna Pai, Rekha B Pai, Meng-yu Xie, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Emergence of a novel mutation in the FLLA region of hepatitis B virus during lamivudine therapyS Balakrishna Pai, A Mithat Bozdayi, Rekha B Pai, et al.
Biomaterials|June 24, 2015
Enhanced therapeutic neovascularization by CD31-expressing cells and embryonic stem cell-derived endothelial cells engineered with chitosan hydrogel containing VEGF-releasing microtubesSangho Lee, Chandra M Valmikinathan, Jaemin Byun, et al.
Nature Materials|February 18, 2014
Guiding intracortical brain tumour cells to an extracortical cytotoxic hydrogel using aligned polymeric nanofibresAnjana Jain, Martha Betancur, Gaurangkumar D Patel, et al.
Antiviral Chemistry & Chemotherapy|July 15, 2003
N4-acyl-modified D-2',3'-dideoxy-5-fluorocytidine nucleoside analogues with improved antiviral activityJunxing Shi, Judy S Mathew, Phillip M Tharnish, et al.
Pageof 3